Episodes

- Guest: Nicholas Kadysh, CEO of PharmAla Biotech, a company pioneering GMP-grade MDMA production and recognized as a top-performing Canadian market stock in 2023. He also serves as Chair of Psychedelics Canada, leading efforts to strengthen legal and ethical standards and advance government engagement and policy in the psychedelic medicine sector. - Core themes: - Biotech innovation in psychedelic-assisted therapies, with a focus on pharmaceutical-grade MDMA manufacturing and compliance. - The evolving future of psychedelic medicine, including clinical translation, regulatory pathways, and integration into healthcare systems. - Policy and public affairs: how industry standards, advocacy, and government collaboration shape responsible growth and patient access in this emerging field. - Takeaways: - PharmAla’s strategy centers on quality, regulatory rigor, and supply readiness for clinical and potential therapeutic use cases. - Industry maturation depends on robust…

In this episode, we sit down with Carolina Alarco, a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. Carolina is the Founder & Principal of Bio Strategy Advisors, serves on multiple biotech and nonprofit boards, and is the Co-Founder & Co-Chair of Latinos in Bio.  She shares insights from her leadership journey at companies like Genzyme, Aegerion Pharmaceuticals, and Novelion Therapeutics, and discusses the future of biotech, the role of angel investing, and why diversity in innovation matters.  Tune in to hear how Carolina is shaping the next generation of biotech leaders and building a more inclusive innovation ecosystem.

In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development.  In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies—pioneering approaches that are shaping the future of cancer treatment.

Robert serves as the CEO for medAppraise Inc., a health technology startup focused on transforming the health and wellness of employees in large industrial corporations through the use of a state-of-the-art musculoskeletal health evaluation solution. In addition, Robert currently serves as president of RNB Ventures Consulting Inc, which is a medical device/technology consultancy firm. RNB Ventures Consulting aim is to provide medical/clinical affairs consulting expertise to medical device and IV...

Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is Inventor, Founder, and Chief Executive Officer of LensGen, Inc., a clinical-stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world, and this led to LensGen closing a $28.0 million Series A Financing in May 2018. Currently, he is also Chairman of t...

Laura Minarsch, R.T. RCIS, CVT, is a senior clinical affairs strategist and President of MMC Medical International Services. She consults for several novel innovative device companies in the MedTech space and has facilitated numerous acquisitions over her career spanning more than 25 years. Her track record is based on successful and strategically planned “First in Human” submissions and clinical studies in Europe, Canada, South America, New Zealand, and Australia. She has been instrumental in d...

Guy Vinograd is CEO at bio-T, a seasoned high-tech executive and an expert software architect of cloud platforms for medical devices. As an industry leader he is a popular speaker and the organizer of the meet-up group: Smart IoMT Product Experts of Israel. Guy has co-founded bio-T, the first and leading medical IoT cloud platform designed to enable medical device vendors to fully realize the potential of the data collected by their devices. Guy is considered a leading expert of Amazon Web Ser...

Dr. Aklog is an adult heart surgeon/entrepreneur and Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a multi-product medical device company which he co-founded based in 2014 on a portfolio of five of his own inventions. He previously co-founded Pavilion Holdings Group LLC which created four medical device companies including venture-backed Vortex Medical which developed and commercialized his life- saving invention AngioVac® and was sold in 2012 to Angiodynamics (Nasdaq: ANGO). Dr. Aklog received...

James F. Jordan is President/CEO at Pittsburgh Life Sciences Greenhouse and a healthcare professor at Carnegie Mellon University. Mr. Jordan is an accomplished Fortune 20-level executive with strong experience in the industry, consulting, and academia and is a recognized expert in market development and guiding the successful formation of entrepreneurial start-up businesses in the life sciences and healthcare industries. Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of a ...